Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
Entrectinib
Potential treatment - theoretical effect Used to treat other disease Antiviral Sep/21/2020
Sildenafil
Potential treatment - theoretical effect Used to treat other disease Other treatment Sep/21/2020
Cefpirome
Potential treatment - theoretical effect Used to treat other disease Other treatment Sep/21/2020
Abemaciclib
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/21/2020
Cefepime
Potential treatment - theoretical effect Used to treat other disease Other treatment Sep/21/2020
4-Chloro-N-[1-(2-quinolin-3-ylethynyl)cyclohexyl]-1H-pyrazole-5-carboxamide
Potential treatment - theoretical effect Experimental Antiviral Sep/21/2020
5-[2-(3-Chlorophenoxy)ethyl]-3-[(2R)-1-pyrrolidin-1-ylsulfonylpyrrolidin-2-yl]-1H-pyrazole
Potential treatment - theoretical effect Experimental Antiviral Sep/21/2020
2-Chloro-N-(4-methylsulfonylphenyl)sulfonyl-5-pyrazol-1-ylbenzamide
Potential treatment - theoretical effect Experimental Antiviral Sep/21/2020
Leflunomide
Potential treatment - clinical evidence Used to treat other disease Other treatment Sep/21/2020
Trefoil factor 2
Potential treatment - clinical evidence Used to treat other disease Other treatment Sep/20/2020
Interferon kappa
Potential treatment - clinical evidence Used to treat other disease Other treatment Sep/20/2020
AR-12
Potential treatment - pre-clinical evidence Experimental Antiviral Sep/20/2020
2.4.1.5. 1-[2-(2‑hydroxy-3‑methoxy-5-(4-carboxyphenylazo) benzaldeneamino)ethyl]−3-methyl-3H-imidazole-3-ium hexafluorophosphate
Potential treatment - theoretical effect Experimental Antiviral Sep/18/2020
Anti-SARS-CoV-2 monobody clone 6b
Potential treatment - pre-clinical evidence Experimental Antiviral Sep/18/2020
Bedoradrine
Potential treatment - theoretical effect Experimental Antiviral Sep/18/2020
N-[(1R)-2-[4-(1-Methylpiperidin-4-yl)piperazin-1-yl]-2-oxo-1-phenylethyl]-1H-indole-6-carboxamide
Approved for COVID-19 treatment (China, India, Russia) Experimental Antiviral Sep/18/2020
N-({(2S)-1-[(3R)-3-Amino-4-(2-fluorophenyl)butanoyl]pyrrolidin-2-YL}methyl)benzamide
Potential treatment - theoretical effect Experimental Antiviral Sep/18/2020
Osimertinib
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/18/2020
6-Carbamimidoyl-4-(3-hydroxy-2-methyl-benzoylamino)-naphthalene-2-carboxylic acid methyl ester
Potential treatment - theoretical effect Experimental Antiviral Sep/18/2020
Fimepinostat
Potential treatment - theoretical effect Experimental Antiviral Sep/18/2020